| 摘要 |
The present invention relates to a pharmaceutical use of actinin-4 involved in induction of cervical cancer. More specifically, provided is a pharmaceutical use of actinin-4, which can be used for diagnosing, preventing, or treating cervical cancer by investigating properties of actinin-4 as a marker protein having inducibility of cervical cancer. |
